Description
BLOOD AND RELATED SERVICES
First action · last action
2008-10-02 · 2008-10-02
Transactions
1
First transaction's obligation
$46,801
Base + all options value (sum of deltas)
$46,801
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA256P0007
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2008-10-02+$46,801= $46,801
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2008-10-02 | +$46,801 | $46,801 | BLOOD AND RELATED SERVICES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PNAEF6YNHFY4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626D0127 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C25626N0210 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6506 · BLOOD AND BLOOD PRODUCTS | $239,128 | FY2026 |
| 36C25626N0209 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6506 · BLOOD AND BLOOD PRODUCTS | $71,646 | FY2026 |
| 36C24926N0133 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS | $390,791 | FY2026 |
| 36C25625N0105 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $144,871 | FY2025 |
| 36C24925N0158 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS | $162,074 | FY2025 |
Other recipients under Q999 from 502-ALEXANDRIA (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25612J1928 | CENLA CHEMICAL DEPENDENCY COUNCIL | 502-ALEXANDRIA | $44,772 | FY2012 |
| VA25612J1925 | CENLA CHEMICAL DEPENDENCY COUNCIL | 502-ALEXANDRIA | $5,208 | FY2012 |
| VA25612J1924 | CENLA CHEMICAL DEPENDENCY COUNCIL | 502-ALEXANDRIA | $11,634 | FY2012 |
| VA25612J1926 | CENLA CHEMICAL DEPENDENCY COUNCIL | 502-ALEXANDRIA | $23,436 | FY2012 |
| VA25612J1929 | CENLA CHEMICAL DEPENDENCY COUNCIL | 502-ALEXANDRIA | $31,668 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_V502C94035_3600_VA256P0007_3600 · retrieved 2026-09-26.